THERMO FISHER SCIENTIFIC INC. (TMO)
Healthcare › Measuring & Controlling Devices, NEC
Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Trading 101% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 5/9 — moderate financial health
- ROE of 11.9% — below-average profitability
THERMO FISHER SCIENTIFIC INC. (TMO) is a Healthcare company operating in Measuring & Controlling Devices, NEC, listed on the NYSE , with a market capitalisation of $176.2 billion . Key value metrics: P/E ratio 27.7, P/B ratio 3.30, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
THERMO FISHER SCIENTIFIC INC. — Fundamental Analysis Summary
THERMO FISHER SCIENTIFIC INC. (TMO) is currently trading 101% above its Graham Number of $235.52, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 27.7x.
On financial health, TMO shows a moderate Piotroski F-Score of 5/9, and modest return on equity of 11.9% (sector average: -19.8%), and manageable leverage with a debt-to-equity ratio of 0.80.
StockPik's composite Value Score for TMO is 52/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
TMO shows revenue growing at 4% year-over-year, with earnings growing at 6%.
TMO pays a modest dividend yield of 0.4%.